articleThe LancetSep 29, 2009Closed access

Ovarian cancer

The University of Texas MD Anderson Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

650
total citations
FWCI
32.79
Percentile
100%
References
128
Citations per year

Authors

3

Topics & keywords

Keywords
  • Debulking
  • Medicine
  • Bevacizumab
  • Ovarian cancer
  • Tumor Debulking
  • Carboplatin
  • Surgery
  • Hysterectomy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.